Alivira's animal health API facility gets US FDA approval

Approval will enable SeQuent Scientific arm to enter the $ 8-bn US veterinary healthcare market

Premium

Image courtesy: Alivira Animal Health Ltd (a part of Sequent Scientific)

BS B2B Bureau Mumbai

Last Updated : May 02 2017 | 3:31 PM IST

Alivira Animal Health Ltd, a wholly owned subsidiary of SeQuent Scientific Limited, has received the US FDA approval for its animal health API (active pharmaceutical ingredients) facility at Visakhapatnam, Andhra Pradesh. With this, Alivira has become the first Indian animal health facility to receive the US FDA approval.

The 225-KL capacity, multi-product facility at Vizag was inspected for the first time by US FDA (Food & Drug Administration) in November 2016 and has now received Establishment Inspection Report (EIR) from US FDA. The receipt of the EIR will enable Alivira’s entry into $ 8 billion US veterinary healthcare market.

“We are pleased

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in